Magnetic resonance imaging of the breast– where are we in 2021?
Magnetic resonance imaging (MRI) is a sensitive and safe radiological method for breast and axillar lymph node imaging. MRI is widely used for diagnostics and follow-up of breast cancer candidates for neoadjuvant chemotherapy. MRI is used to assess tumor response to chemotherapy in these patients an...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University Hospital for Tumors
2021-01-01
|
| Series: | Libri Oncologici |
| Subjects: | |
| Online Access: | https://hrcak.srce.hr/file/389011 |
| _version_ | 1827282203745189888 |
|---|---|
| author | Mirta Zekan-Vučetić Saša Schmidt Helga Sertić-Milić Jelena Popić Ljubica Luetić-Cavor Borki Vučetić |
| author_facet | Mirta Zekan-Vučetić Saša Schmidt Helga Sertić-Milić Jelena Popić Ljubica Luetić-Cavor Borki Vučetić |
| author_sort | Mirta Zekan-Vučetić |
| collection | DOAJ |
| description | Magnetic resonance imaging (MRI) is a sensitive and safe radiological method for breast and axillar lymph node imaging. MRI is widely used for diagnostics and follow-up of breast cancer candidates for neoadjuvant chemotherapy. MRI is used to assess tumor response to chemotherapy in these patients and help plan the type of surgical procedure needed after the therapy.
Also, preoperative MRI changes the surgical approach in 11-16% of the cases and depicts the occult tumor in the contralateral breast in 3-4% of patients whose primary treatment is surgery.
Several studies in recent years, some on more than a thousand patients, have shown usefulness of breast MRI for planning surgical approaches reducing the number of patients with positive resection margins, thus reducing the number of patients who need reoperation.
In future, we should aim to include MRI of the breast as a diagnostic tool in more, if not all, patients diagnosed with breast cancer. |
| first_indexed | 2024-04-24T09:14:11Z |
| format | Article |
| id | doaj.art-c9a9f0c273ff425f85453489a86ce47a |
| institution | Directory Open Access Journal |
| issn | 0300-8142 2584-3826 |
| language | English |
| last_indexed | 2024-04-24T09:14:11Z |
| publishDate | 2021-01-01 |
| publisher | University Hospital for Tumors |
| record_format | Article |
| series | Libri Oncologici |
| spelling | doaj.art-c9a9f0c273ff425f85453489a86ce47a2024-04-15T17:23:54ZengUniversity Hospital for TumorsLibri Oncologici0300-81422584-38262021-01-01492-3808610.20471/LO.2021.49.02-03.11Magnetic resonance imaging of the breast– where are we in 2021?Mirta Zekan-Vučetić0Saša Schmidt1Helga Sertić-Milić2Jelena Popić3Ljubica Luetić-Cavor4Borki Vučetić5Department for Diagnostic and Interventional Radiology, Clinical Hospital Merkur, Zagreb, CroatiaDepartment for Diagnostic and Interventional Radiology, Clinical Hospital Merkur, Zagreb, CroatiaDepartment for Diagnostic and Interventional Radiology, Clinical Hospital Merkur, Zagreb, CroatiaDepartment for Diagnostic and Interventional Radiology, Clinical Hospital Merkur, Zagreb, CroatiaClinical Department for Diagnostic and Interventional Radiology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaClinical Department for Surgery, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaMagnetic resonance imaging (MRI) is a sensitive and safe radiological method for breast and axillar lymph node imaging. MRI is widely used for diagnostics and follow-up of breast cancer candidates for neoadjuvant chemotherapy. MRI is used to assess tumor response to chemotherapy in these patients and help plan the type of surgical procedure needed after the therapy. Also, preoperative MRI changes the surgical approach in 11-16% of the cases and depicts the occult tumor in the contralateral breast in 3-4% of patients whose primary treatment is surgery. Several studies in recent years, some on more than a thousand patients, have shown usefulness of breast MRI for planning surgical approaches reducing the number of patients with positive resection margins, thus reducing the number of patients who need reoperation. In future, we should aim to include MRI of the breast as a diagnostic tool in more, if not all, patients diagnosed with breast cancer.https://hrcak.srce.hr/file/389011breast MRIneoadjuvant chemotherapyearly breast cancer |
| spellingShingle | Mirta Zekan-Vučetić Saša Schmidt Helga Sertić-Milić Jelena Popić Ljubica Luetić-Cavor Borki Vučetić Magnetic resonance imaging of the breast– where are we in 2021? Libri Oncologici breast MRI neoadjuvant chemotherapy early breast cancer |
| title | Magnetic resonance imaging of the breast– where are we in 2021? |
| title_full | Magnetic resonance imaging of the breast– where are we in 2021? |
| title_fullStr | Magnetic resonance imaging of the breast– where are we in 2021? |
| title_full_unstemmed | Magnetic resonance imaging of the breast– where are we in 2021? |
| title_short | Magnetic resonance imaging of the breast– where are we in 2021? |
| title_sort | magnetic resonance imaging of the breast where are we in 2021 |
| topic | breast MRI neoadjuvant chemotherapy early breast cancer |
| url | https://hrcak.srce.hr/file/389011 |
| work_keys_str_mv | AT mirtazekanvucetic magneticresonanceimagingofthebreastwherearewein2021 AT sasaschmidt magneticresonanceimagingofthebreastwherearewein2021 AT helgaserticmilic magneticresonanceimagingofthebreastwherearewein2021 AT jelenapopic magneticresonanceimagingofthebreastwherearewein2021 AT ljubicalueticcavor magneticresonanceimagingofthebreastwherearewein2021 AT borkivucetic magneticresonanceimagingofthebreastwherearewein2021 |